Bonura, F.; Genovese, D.; Amodio, E.; Calamusa, G.; Sanfilippo, G.L.; Cacioppo, F.; Giammanco, G.M.; De Grazia, S.; Ferraro, D.
Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination. Vaccines 2022, 10, 874.
https://doi.org/10.3390/vaccines10060874
AMA Style
Bonura F, Genovese D, Amodio E, Calamusa G, Sanfilippo GL, Cacioppo F, Giammanco GM, De Grazia S, Ferraro D.
Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination. Vaccines. 2022; 10(6):874.
https://doi.org/10.3390/vaccines10060874
Chicago/Turabian Style
Bonura, Floriana, Dario Genovese, Emanuele Amodio, Giuseppe Calamusa, Giuseppa Luisa Sanfilippo, Federica Cacioppo, Giovanni Maurizio Giammanco, Simona De Grazia, and Donatella Ferraro.
2022. "Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination" Vaccines 10, no. 6: 874.
https://doi.org/10.3390/vaccines10060874
APA Style
Bonura, F., Genovese, D., Amodio, E., Calamusa, G., Sanfilippo, G. L., Cacioppo, F., Giammanco, G. M., De Grazia, S., & Ferraro, D.
(2022). Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination. Vaccines, 10(6), 874.
https://doi.org/10.3390/vaccines10060874
